HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serotonin depletion effects on the pilocarpine model of epilepsy.

Abstract
The monoamine content in cerebral structures has been related to neuronal excitability and several approaches have been used to study this phenomenon during seizure vulnerability. In the present work, we have described the effects of serotonin (5-HT) depletion after the administration of 5,7-dihydroxytryptamine (5,7-DHT) into the median raphe nucleus in rats submitted to the pilocarpine model of epilepsy. Susceptibility to pilocarpine-induced status epilepticus as well as the spontaneous seizure frequency during the chronic period of the model was determined. Since the hippocampus is one of the main structures in the development of this epilepsy model, the 5-HT levels in this region were also determined after drug administration. Sixty-three percent of 5,7-DHT pre-treated rats (15/24) and only 33.4% of those receiving the control solution (9/24) progressed to motor limbic seizures evolving to status epilepticus, following the administration of pilocarpine. The frequency of seizures during the chronic period, in epileptic rats that received 5,7-DHT, showed a significant (58%) increase after the treatment, when compared with control group. Our data showed that serotonin may play an important role on seizure activity which seems to be exerted by its inhibitory action on the expression of overt behavior seizures departing from an established focus in the limbic system.
AuthorsEuclides Maurício Trindade-Filho, Eduardo Ferreira de Castro-Neto, Reinaldo de A Carvalho, Eliangela Lima, Fulvio Alexandre Scorza, Débora Amado, Maria da Graça Naffah-Mazzacoratti, Esper Abrão Cavalheiro
JournalEpilepsy research (Epilepsy Res) Vol. 82 Issue 2-3 Pg. 194-9 (Dec 2008) ISSN: 1872-6844 [Electronic] Netherlands
PMID18845420 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Muscarinic Agonists
  • Serotonin Antagonists
  • Pilocarpine
  • 5,7-Dihydroxytryptamine
  • Serotonin
Topics
  • 5,7-Dihydroxytryptamine (toxicity)
  • Acute Disease
  • Animals
  • Behavior, Animal
  • Chronic Disease
  • Disease Models, Animal
  • Disease Susceptibility
  • Electroencephalography
  • Epilepsies, Partial (chemically induced, physiopathology)
  • Hippocampus (chemistry)
  • Male
  • Muscarinic Agonists (toxicity)
  • Pilocarpine (toxicity)
  • Raphe Nuclei (drug effects, physiopathology)
  • Rats
  • Rats, Wistar
  • Recurrence
  • Serotonin (analysis, physiology)
  • Serotonin Antagonists (toxicity)
  • Status Epilepticus (chemically induced, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: